PALISADE BIO, INC.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
PALI$1.13-5.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
ance Sheets (Unaudited)
(in thousands, except share and per share amounts)
| September 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $113,613 | $133,385 |
| Prepaid expenses and other current assets | 3,860 | 836 |
| Total current assets | 117,473 | 134,221 |
| Restricted cash | 55 | 55 |
| Other noncurrent assets | 1,017 | 68 |
| Total assets | $118,545 | $134,344 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,445 | $767 |
| Accrued liabilities | 3,608 | 2,187 |
| Accrued compensation and benefits | 773 | 1,298 |
| Share liability | — | 313 |
| Insurance financing debt | — | 71 |
| Total current liabilities | 5,826 | 4,636 |
| Noncurrent liabilities | 279 | 328 |
| Total liabilities | 6,105 | 4,964 |
| Commitments and contingencies (Note 9) | ||
| Stockholders' equity: | ||
| Series A Convertible Preferred Stock, $0.01 par value, 7,000,000 shares authorized; 200,000 issued and outstanding at September 30, 2026 and December 31, 2025 | 2 | 2 |
| Common stock, $0.01 par value; 450,000,000 and 300,000,000 shares authorized; 174,442,971 and 159,444,017 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | 1,744 | 1,594 |
| Additional paid-in capital | 298,216 | 280,509 |
| Accumulated deficit | (187,522) | (152,725) |
| Total stockholders' equity | 112,440 | 129,380 |
| Total liabilities and stockholders' equity | $118,545 | $134,344 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.